SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001493152-24-011321
Filing Date
2024-03-26
Accepted
2024-03-26 16:44:13
Documents
77

Document Format Files

Seq Description Document Type Size
1 forms-1a.htm   iXBRL S-1/A 2513554
2 ex5.htm EX-5 27778
3 ex23-2.htm EX-23.2 2443
4 ex107.htm EX-FILING FEES 66390
5 ex5_001.jpg GRAPHIC 2601
6 ex5_002.jpg GRAPHIC 2626
7 ex5_003.jpg GRAPHIC 2627
8 forms-1_001.jpg GRAPHIC 7976
  Complete submission text file 0001493152-24-011321.txt   9678956

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE ensc-20231231.xsd EX-101.SCH 66736
10 XBRL CALCULATION FILE ensc-20231231_cal.xml EX-101.CAL 65544
11 XBRL DEFINITION FILE ensc-20231231_def.xml EX-101.DEF 279625
12 XBRL LABEL FILE ensc-20231231_lab.xml EX-101.LAB 493860
13 XBRL PRESENTATION FILE ensc-20231231_pre.xml EX-101.PRE 380378
81 EXTRACTED XBRL INSTANCE DOCUMENT forms-1a_htm.xml XML 1457925
Mailing Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037
Business Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037 (858) 263-4196
Ensysce Biosciences, Inc. (Filer) CIK: 0001716947 (see all company filings)

IRS No.: 822755287 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-276537 | Film No.: 24784286
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)